MRVI — Maravai Lifesciences Holdings Share News
0.000.00%
Last trade - 00:00- $1.84bn
- $2.09bn
- $185.74m
Brief: Maravai Lifesciences Temporarily Reinstates Carl Hull As CEO Amidst Pending Noncompetition Litigation
Brief: Maravai Lifesciences Announces CEO Leadership Transition
Brief: Trilink Biotechnologies Expands Its mRNA Raw Material Offering
U.S. RESEARCH ROUNDUP-Alnylam Pharmaceuticals, Coupa Software, Docusign
Maravai LifeSciences Holdings Inc reports results for the quarter ended in June - Earnings Summary
Brief: Maravai Lifesciences Reports Q2 Financial Results
Maravai LifeSciences Holdings Inc expected to post earnings of 45 cents a share - Earnings Preview
Brief: Maravai LifeSciences Unit Announces Agreement With Department Of Defense
U.S. RESEARCH ROUNDUP-Eli Lilly, Gilead Sciences, Upwork
Maravai LifeSciences Holdings Inc reports results for the quarter ended in March - Earnings Summary
Brief: Maravai Lifesciences Reports First Quarter 2022 Financial Results
Maravai LifeSciences Holdings Inc expected to post earnings of 44 cents a share - Earnings Preview
Sartorius sticks to 2022 outlook despite rising costs, Ukraine (updated)
Brief: Bio-Techne And Cygnus Technologies Introduce New Simple Plex Hek 293 Hcp 3G Immunoassay
Buyout firms GTCR, CD&R circle Merit Medical -sources
German stocks - Factors to watch on Feb 28
Sartorius in $11 bln bid for COVID vaccine reagent vendor Maravai -sources
Sartorius in $11 bln bid for COVID vaccine reagent vendor Maravai -sources
Maravai LifeSciences Holdings Inc reports results for the quarter ended in December - Earnings Summary